Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are we really that blind?

Egbert A van der Meulen1

  • 1Clinical Trial Operations/Biometrics, NV Organon, Oss, The Netherlands. bert.vandermeulen@organon.com

Journal of Biopharmaceutical Statistics
|June 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria.

European urology focus·2018
Same author

Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

The Journal of urology·2013
Same author

Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

The Journal of urology·2013
Same author

Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2010

Blinded statistical inference in clinical trials is possible, providing precise treatment effect estimates and standard deviations even with block randomization. This capability may reduce the need for interim analyses, but alternative randomization methods could be considered.

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Pharmaceutical Research

Background:

  • Double-blind randomized clinical trials commonly use permuted block randomization.
  • Current practices often necessitate unblinding for statistical inference and sample size reestimation.

Purpose of the Study:

  • To demonstrate the feasibility of conducting statistical inference on treatment effects and within-group standard deviation from blinded data in clinical trials.
  • To explore the implications of blinded inference for interim analyses and randomization strategies.

Main Methods:

  • Statistical analysis of data from double-blind randomized clinical trials utilizing permuted block randomization.
  • Evaluation of estimation precision for treatment effects and standard deviations under blinded conditions.

Related Experiment Videos

Main Results:

  • Consistent and precise estimates of treatment effects can be obtained from blinded data, even with additive block effects.
  • Within-group standard deviation, crucial for power calculations, can be inferred with high precision from blinded data.
  • Random block lengths, while complicating analysis, do not significantly impede blinded inference.

Conclusions:

  • Blinded inference offers a viable alternative to traditional interim analyses for certain trial aspects, particularly in non-pivotal trials.
  • The possibility of blinded inference supports the use of large blocks in randomization, as precision decreases with larger block sizes.
  • Consideration of alternative randomization procedures (e.g., dynamic allocation) may be warranted if regulators wish to avoid the implications of blinded inference.